JP6801835B2 - β−ターンペプチド模倣環状塩の液相合成及び結晶化 - Google Patents

β−ターンペプチド模倣環状塩の液相合成及び結晶化 Download PDF

Info

Publication number
JP6801835B2
JP6801835B2 JP2017567608A JP2017567608A JP6801835B2 JP 6801835 B2 JP6801835 B2 JP 6801835B2 JP 2017567608 A JP2017567608 A JP 2017567608A JP 2017567608 A JP2017567608 A JP 2017567608A JP 6801835 B2 JP6801835 B2 JP 6801835B2
Authority
JP
Japan
Prior art keywords
compound
formula
salt
hcl
crystalline form
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017567608A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018528928A5 (OSRAM
JP2018528928A (ja
Inventor
シャンタル デヴィン，
シャンタル デヴィン，
ウェイ ティアン，
ウェイ ティアン，
マルティン ボーリン，
マルティン ボーリン，
セバスチャン ロッチ，
セバスチャン ロッチ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mimetogen Pharmaceuticals Inc
Original Assignee
Mimetogen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mimetogen Pharmaceuticals Inc filed Critical Mimetogen Pharmaceuticals Inc
Publication of JP2018528928A publication Critical patent/JP2018528928A/ja
Publication of JP2018528928A5 publication Critical patent/JP2018528928A5/ja
Application granted granted Critical
Publication of JP6801835B2 publication Critical patent/JP6801835B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/306—Extraction; Separation; Purification by precipitation by crystallization
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2017567608A 2015-07-09 2016-07-08 β−ターンペプチド模倣環状塩の液相合成及び結晶化 Active JP6801835B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562190596P 2015-07-09 2015-07-09
US62/190,596 2015-07-09
PCT/EP2016/066281 WO2017005902A1 (en) 2015-07-09 2016-07-08 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

Publications (3)

Publication Number Publication Date
JP2018528928A JP2018528928A (ja) 2018-10-04
JP2018528928A5 JP2018528928A5 (OSRAM) 2019-04-18
JP6801835B2 true JP6801835B2 (ja) 2020-12-16

Family

ID=56413639

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017567608A Active JP6801835B2 (ja) 2015-07-09 2016-07-08 β−ターンペプチド模倣環状塩の液相合成及び結晶化

Country Status (9)

Country Link
US (4) US10125165B2 (OSRAM)
EP (2) EP3319978B1 (OSRAM)
JP (1) JP6801835B2 (OSRAM)
KR (1) KR102056257B1 (OSRAM)
CN (2) CN114874288A (OSRAM)
AU (1) AU2016290654C1 (OSRAM)
CA (1) CA2991661A1 (OSRAM)
TW (1) TWI708779B (OSRAM)
WO (1) WO2017005902A1 (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6801835B2 (ja) 2015-07-09 2020-12-16 ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． β−ターンペプチド模倣環状塩の液相合成及び結晶化
PL3464336T3 (pl) 2016-06-01 2022-05-16 Athira Pharma, Inc. Związki
MX2020012629A (es) * 2018-05-31 2021-01-29 Sederma Sa Metodo para sintesis de peptido en fase de solucion y estrategias protectoras de la misma.
US11427612B2 (en) * 2018-08-21 2022-08-30 Wayne State University Epimerization-free N to C solid-phase peptide synthesis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP254898A0 (en) * 1998-03-24 1998-04-23 University Of Queensland, The Peptide turn mimetics
WO2001052843A1 (en) 2000-01-18 2001-07-26 Mcgill University β-TURN PEPTIDOMIMETIC CYCLIC COMPOUNDS
BR0311558A (pt) * 2002-06-11 2007-04-27 Lilly Co Eli composto ou sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, métodos para afetar os receptores de glutamato metabotrópicos ligados a camp, para administrar uma quantidade eficaz de um composto e para tratar um distúrbio neurológico e psiquiátrico em um paciente, e, formulação farmacêutica
KR101565185B1 (ko) * 2008-04-04 2015-11-02 미메토젠 파르마슈티칼스 인크. 건안증을 치료하기 위한 베타-턴 펩티도미메틱 환상 화합물
ES2512717T3 (es) * 2009-02-27 2014-10-24 Mimetogen Pharmaceuticals Inc. Compuestos cíclicos peptidomiméticos para el tratamiento de la retinitis pigmentosa
WO2012013281A1 (de) * 2010-07-29 2012-02-02 Merck Patent Gmbh Flüssigkristallines medium enthaltend thiophenderivate
JP5710436B2 (ja) * 2011-09-26 2015-04-30 株式会社東芝 パターン形成方法
KR102061382B1 (ko) * 2012-06-22 2019-12-31 미메토젠 파르마슈티칼스 인크. 베타-턴 펩티도미메틱 환상 화합물의 합성
JP6516974B2 (ja) * 2013-06-14 2019-05-22 豊田合成株式会社 ゴム組成物及びゴム製品
US9200100B2 (en) * 2013-06-20 2015-12-01 Exxonmobil Chemical Patents Inc. Long-bridged salen catalyst
JP6801835B2 (ja) * 2015-07-09 2020-12-16 ミメトゲン ファーマシュウティカルズ インコーポレイテッドＭｉｍｅｔｏｇｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． β−ターンペプチド模倣環状塩の液相合成及び結晶化

Also Published As

Publication number Publication date
US11078234B2 (en) 2021-08-03
CN107849089B (zh) 2022-07-05
CN114874288A (zh) 2022-08-09
EP3319978A1 (en) 2018-05-16
US20210300966A1 (en) 2021-09-30
TW201716425A (zh) 2017-05-16
US20170008923A1 (en) 2017-01-12
EP4549450A2 (en) 2025-05-07
WO2017005902A1 (en) 2017-01-12
AU2016290654A1 (en) 2018-01-25
EP4549450A3 (en) 2025-07-02
HK1255355A1 (en) 2019-08-16
US11753441B2 (en) 2023-09-12
US20190194251A1 (en) 2019-06-27
CA2991661A1 (en) 2017-01-12
US12281179B2 (en) 2025-04-22
KR20180036982A (ko) 2018-04-10
TWI708779B (zh) 2020-11-01
KR102056257B1 (ko) 2019-12-16
AU2016290654C1 (en) 2021-11-11
CN107849089A (zh) 2018-03-27
EP3319978C0 (en) 2025-02-19
JP2018528928A (ja) 2018-10-04
EP3319978B1 (en) 2025-02-19
AU2016290654B2 (en) 2021-07-08
US20230357318A1 (en) 2023-11-09
US10125165B2 (en) 2018-11-13
AU2016290654A2 (en) 2020-08-06

Similar Documents

Publication Publication Date Title
US12281179B2 (en) Solution phase synthesis of β-turn peptidomimetic cyclic salts
CN114630835B (zh) 包含空间位阻大的氨基酸的肽化合物的制备方法
EP2873677B1 (en) Method of producing self-assembling peptide derivative
TW202235429A (zh) 含ｎ－置換－胺基酸殘基之胜肽化合物的製備方法
JP6500105B2 (ja) ペプチドが結合された安定したアスコルビン酸誘導体、その製造方法、及びそれを含む化粧料組成物
WO2023127869A1 (ja) Ｎ－アルキルアミノ酸、およびｎ－アルキルアミノ酸を含むペプチドの製造方法
WO2022097540A1 (ja) ジケトピペラジン形成による欠損を抑制するペプチド合成方法
US20130281384A1 (en) Larazotide acetate compositions
JP2018509376A5 (OSRAM)
CA2909584C (en) Synthesis of beta-turn peptidomimetic cyclic compounds
HK40081202A (en) Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
HK1255355B (en) Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts
CN102875643A (zh) 用于合成生长抑素的主要肽片段
US9605020B2 (en) Method for producing dipeptide derivative containing disubstituted amino acid residue
US20250353810A1 (en) Process for the preparation of trofinetide
RU2574392C1 (ru) СПОСОБ ПОЛУЧЕНИЯ ТРИПЕПТИДА ОБЩЕЙ ФОРМУЛЫ (I) HPyr-His-TrpOH, ИСПОЛЬЗУЕМОГО В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО СОЕДИНЕНИЯ (1-3 ФРАГМЕНТА) В СИНТЕЗЕ СИНТЕТИЧЕСКИХ АГОНИСТОВ ГОНАДОТРОПИН-РИЛИЗИНГ-ГОРМОНА (LH-RH), МЕТОДОМ ЖИДКОФАЗНОГО ПЕПТИДНОГО СИНТЕЗА БЕЗ ПОСТАНОВКИ И СНЯТИЙ ЗАЩИТНЫХ ГРУПП
CN108864252A (zh) 制备nrx-1074的方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190311

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190311

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20190918

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200601

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20201027

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20201110

R150 Certificate of patent or registration of utility model

Ref document number: 6801835

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250